The debate continues over the potential of measurable residual disease to transform research and clinical care in hematology.

Ravindra Uppaluri, MD, PhD, discusses the background regarding locally advanced head and neck cancer and what the trial design of KEYNOTE-689 entailed.

The Dow Jones Industrial Average (DJINDICES: ^DJI) index edged 3.9% higher in May, with 70% of its 30 constituent stocks ...

During a Community Case Forum event, Adil Daud, MD, discussed immunotherapy options for cutaneous squamous cell carcinoma.

Merck Animal Health receives EU CVMP positive opinion for Numelvi tablets for dogs: Rahway, New Jersey Saturday, June 14, 2025, 13:00 Hrs [IST] Merck Animal Health, known as MSD A ...

Cancer Biomarkers Market Advancement Cancer Biomarkers Market Research Report Information By Biomarker Type, By Cancer Type, By Profiling T ...

A former Harvard Medical School professor who claims he was fired for refusing to receive the Covid-19 vaccine was appointed ...

Benchling announced a new collaboration with Merck, known as MSD outside of the United States and Canada, to implement a ...

Among the eight people Robert F. Kennedy Jr. announced would make up his new group of outside vaccine advisers to the US ...

Three of the health secretary’s picks to replace fired members of an influential panel that sets U.S. vaccine policies have ...

A federal judge in California ordered the State Department to temporarily hold off on firing nearly 1,900 employees as planned. Read more › Voter ID: A federal judge on Friday indefinitely blocked ...

Wasserman promotes Shelley Pisarra to chief insights and innovation officer; Anthem Music Publishing acquires song catalog ...